KoBioLabs, Inc (KOSDAQ:348150)
South Korea · Delayed Price · Currency is KRW 3,780.00
+170.00 (4.71%)
At close: Jun 5, 2026
KoBioLabs Market Cap
KoBioLabs has a market cap or net worth of 73.4 billion as of June 8, 2026. Its market cap has decreased by -22.46% in one year.
Market Cap
73.40B
Enterprise Value
59.71B
Revenue
71.21B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,780.00
Market Cap Chart
Since November 18, 2020, KoBioLabs's market cap has decreased from 493.16B to 73.40B, a decrease of -85.12%. That is a compound annual growth rate of -29.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 73.40B | -34.03% |
| Dec 30, 2025 | 111.27B | 7.15% |
| Dec 30, 2024 | 103.84B | -35.34% |
| Dec 28, 2023 | 160.60B | -16.02% |
| Dec 29, 2022 | 191.23B | -42.95% |
| Dec 30, 2021 | 335.17B | -50.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BIO-FD&C | 84.44B |
| CTCBIO | 78.30B |
| Naturalendo Tech | 75.78B |
| SunBio,Inc. | 75.72B |
| AriBioLab | 71.19B |
| Ark Solutions | 68.91B |
| TegoScience | 68.54B |
| PanGen Biotech | 67.98B |